ABSTRACT
Indiscriminate use of antibiotics has led to the emergence of antibiotic-resistant microbes and the loss of natural flora in aquaculture systems necessitating the ban of many of these chemotherapeutants in aquaculture. Actinobacteria play a profound role in the biogeochemical cycling in the marine environment and represent the principal source of secondary metabolites with antimicrobial property. In the present study, 98 marine-derived actinomycete isolates were screened for antimicrobial activity against the common aquatic pathogens. A potent actinomycete isolate S26, identified as Streptomyces variabilis based on 16 S ribosomal RNA (rRNA) gene sequencing was then checked for the production of antibiotic in five different fermentation media and the one which showed maximum production was chosen for further study. Optimization of the fermentation medium for secondary metabolite production was carried out by response surface methodology (RSM) using DESIGN EXPERT. The analysis of variance (ANOVA) of the quadratic regression model demonstrated that the model was highly significant for the response concerned that is, antimicrobial activity as evident from the Fisher's F- test with a very low probability value [(P model>F) = 0.0001]. Of the 10 different solutions suggested by the software, the most suitable composition was found to be starch, 1.38%; soy powder, 0.88%; ammonium sulfate, 0.16% and salinity, 27.76. S. variabilis S26 cultured in the optimized production medium was applied in the Penaeus monodon larval rearing system and the total Vibrio count and survival rate were estimated. S. variabilis S26 treatment showed a significant reduction in vibrios and conferred better protection to P. monodon in culture system compared with control.
Subject(s)
Actinobacteria , Anti-Infective Agents , Penaeidae , Streptomyces , Vibrio Infections , Vibrio , Animals , Actinobacteria/genetics , Actinobacteria/metabolism , Larva/microbiology , Vibrio Infections/prevention & control , Anti-Bacterial Agents/metabolism , Anti-Infective Agents/metabolism , Penaeidae/microbiologyABSTRACT
BACKGROUND: Infections caused by Nocardia farcinica are potentially lethal because of the organism's tendency to disseminate and resist antibiotics. Central nervous system involvement has been documented in 30% of infections caused N. farcinica. METHODS: Case report and review of the literature. RESULTS: A case of primary brain abscess caused by N. farcinica, identified by 16SrRNA sequencing, is presented, and 39 cases reported previously in the literature are reviewed. Our patient underwent a neuronavigation-guided right frontal craniotomy and was treated with trimethoprim/sulfamethoxazole and amoxicillin-clavulanic acid for 12 mo. He showed marginal improvement in his prior left hemiparesis at the last review 14 months later. CONCLUSION: Cases of N. farcinica infections are being reported increasingly because of recent changes in taxonomy and diagnostic methodology. This change in epidemiology has implications for therapy because of the organism's pathogenicity and natural resistance to multiple antimicrobial agents, including third-generation cephalosporins. Any delay in starting appropriate antibiotic therapy can have adverse consequences.
Subject(s)
Brain Abscess/microbiology , Nocardia Infections/pathology , Nocardia/isolation & purification , Adult , Aged , Female , Humans , Male , Middle Aged , Young AdultABSTRACT
Leuconostoc garlicum, belonging to the family of Leuconostocaceae, is a catalase-negative, Gram-positive ovoid cocci, intrinsically resistant to vancomycin. Clinical infection by Leuconostoc garlicum is rare. We report a case of respiratory tract infection subsequent to vancomycin therapy.
Subject(s)
Acinetobacter Infections/drug therapy , Acinetobacter baumannii/isolation & purification , Leuconostoc/isolation & purification , Respiratory Tract Infections/drug therapy , Respiratory Tract Infections/microbiology , Vancomycin Resistance , Acinetobacter Infections/microbiology , Adolescent , Anti-Bacterial Agents/therapeutic use , Carbapenems/therapeutic use , Colistin/therapeutic use , Drug Resistance, Multiple, Bacterial , Fatal Outcome , Female , Humans , Minocycline/analogs & derivatives , Minocycline/therapeutic use , TigecyclineABSTRACT
Coryneform bacteria belonging to the genus Brevibacterium have emerged as opportunistic pathogens. Of the nine known species of Brevibacterium isolated from human clinical samples, Brevibacterium casei is the most frequently reported species from clinical specimens. We report the first case of B. casei brain abscess in an immunocompetent patient successfully treated by surgery and antimicrobial therapy.
Subject(s)
Actinomycetales Infections/diagnosis , Actinomycetales Infections/microbiology , Brain Abscess/diagnosis , Brain Abscess/microbiology , Brevibacterium/classification , Brevibacterium/isolation & purification , Actinomycetales Infections/pathology , Actinomycetales Infections/therapy , Adult , Anti-Bacterial Agents/administration & dosage , Brain/diagnostic imaging , Brain/pathology , Brain Abscess/pathology , Brain Abscess/therapy , Brevibacterium/genetics , DNA, Bacterial/chemistry , DNA, Bacterial/genetics , DNA, Ribosomal/chemistry , DNA, Ribosomal/genetics , Debridement , Humans , Magnetic Resonance Imaging , Male , Molecular Sequence Data , RNA, Ribosomal, 16S/genetics , Radiography , Sequence Analysis, DNAABSTRACT
We describe a case of bacteraemia caused by Weissella confusa in a 48-year-old male who was operated on for adenocarcinoma of the gastro-oesophageal junction and maintained on total parenteral nutrition. Blood cultures were positive for a vancomycin-resistant streptococcus-like organism which was identified as W. confusa by 16S rRNA gene sequencing.